Direct intrathecal implantation of mesenchymal stromal cells leads to enhanced neuroprotection via an NFκB-mediated increase in interleukin-6 production

Stem Cells and Development

Volumn 19, Issue 6, 2010, Pages 867-876

  Walker, Peter A ^a   Harting, Matthew T ^a   Jimenez, Fernando ^a   Shah, Shinil K ^a,b   Pati, Shibani ^a   Dash, Pramod K ^a   Cox, Charles S ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; EDOXUDINE; I KAPPA B; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN HOMOGENATE; BRAIN TISSUE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STROMAL CELL; MESENCHYME CELL; MULTIPLEX POLYMERASE CHAIN REACTION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; SUPERNATANT;

ANIMALS; BRAIN; CELL PROLIFERATION; COCULTURE TECHNIQUES; CULTURE MEDIA; CYTOPROTECTION; GENE EXPRESSION REGULATION; INJECTIONS, SPINAL; INTERLEUKIN-6; LUCIFERASES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MODELS, BIOLOGICAL; NEURONS; NF-KAPPA B; PROSTHESIS IMPLANTATION; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROMAL CELLS; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 77954189278     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0188     Document Type: Article

References (29)

1. Thurman DJ, C Alverson, KA Dunn, J Guerrero and JE Sniezek. (1999). Traumatic brain injury in the United States: A public health perspective. J Head Trauma Rehabil 14:602-615.
2. -(1999). Consensus conference. Rehabilitation of persons with traumatic brain injury. NIH consensus development panel on rehabilitation of persons with traumatic brain injury. JAMA 282:974-983.
3. Faul M, MM Wald, W Rutland-Brown, EE Sullivent and RW Sattin. (2007). Using a cost-benefi t analysis to estimate outcomes of a clinical treatment guideline: testing the Brain Trauma Foundation guidelines for the treatment of severe traumatic brain injury. J Trauma 63:1271-1278.
4. Walker PA, SK Shah, MT Harting and CS Cox. (2009). Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation. Dis Model Mech 2:23-38.
5. Qu C, A Mahmood, D Lu, A Goussev, Y Xiong and M Chopp. (2008). Treatment of traumatic brain injury in mice with marrow stromal cells. Brain Res 1208:234-239.
6. Liao W, J Xie, J Zhong, Y Liu, L Du, B Zhou, J Xu, P Liu, S Yang, J Wang, Z Han and ZC Han. (2009). Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation 87:350-359.
7. Lim JH, YE Byeon, HH Ryu, YH Jeong, YW Lee, WH Kim, KS Kang and OK Kweon. (2007). Transplantation of canine umbilical cord blood-derived mesenchymal stem cells in experimentally induced spinal cord injured dogs. J Vet Sci 8:275-282.
8. Zhao LR, WM Duan, M Reyes, CD Keene, CM Verfaillie and WC Low. (2002). Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological defi cits after grafting into the ischemic brain of rats. Exp Neurol 174:11-20.
9. Deng J, BE Petersen, DA Steindler, ML Jorgensen and ED Laywell. (2006). Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation. Stem Cells 24:1054-1064.
10. English D, SK Klasko and PR Sanberg. (2006). Elusive mechanisms of "stem cell"-mediated repair of cerebral damage. Exp Neurol 199:10-15.
11. Castro RF, KA Jackson, MA Goodell, CS Robertson, H Liu and HD Shine. (2002). Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science 297:1299.
12. Aggarwal S and MF Pittenger. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822.
13. Nemeth K, A Leelahavanichkul, PS Yuen, B Mayer, A Parmelee, K Doi, PG Robey, K Leelahavanichkul, BH Koller, JM Brown, X Hu, I Jelinek, RA Star and E Mezey. (2009). Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15:42-49.
14. Coyne TM, AJ Marcus, D Woodbury and IB Black. (2006). Marrow stromal cells transplanted to the adult brain are rejected by an infl ammatory response and transfer donor labels to host neurons and glia. Stem Cells 24:2483-2492.
15. Nijboer CH, CJ Heijnen, F Groenendaal, MJ May, F van Bel and A Kavelaars. (2008). A dual role of the NF-kappaB pathway in neonatal hypoxic-ischemic brain damage. Stroke 39:2578-2586.
16. Harting MT, F Jimenez, SD Adams, DW Mercer and CS Cox, Jr. (2008). Acute, regional infl ammatory response after traumatic brain injury: Implications for cellular therapy. Surgery 144:803-813.
17. Lighthall JW. (1988). Controlled cortical impact: a new experimental brain injury model. J Neurotrauma 5:1-15.
18. Harting MT, LE Sloan, F Jimenez, J Baumgartner and CS Cox, Jr. (2009). Subacute neural stem cell therapy for traumatic brain injury. J Surg Res 153:188-194.
19. Penolazzi L, E Lambertini, E Tavanti, E Torreggiani, F Vesce, R Gambari and R Piva. (2008). Evaluation of chemokine and cytokine profi les in osteoblast progenitors from umbilical cord blood stem cells by BIO-PLEX technology. Cell Biol Int 32:320-325.
20. Adams SD, RS Radhakrishnan, KS Helmer and DW Mercer. (2008). Effects of anesthesia on lipopolysaccharide-induced changes in serum cytokines. J Trauma 65:170-174.
21. Harting MT, LE Sloan, F Jimenez, J Baumgartner and CS Cox, Jr. (2009). Subacute neural stem cell therapy for traumatic brain injury. J Surg Res 153:188-194.
22. Harting M, F Jimenez, S Pati, J Baumgartner and C Cox, Jr. (2008). Immunophenotype characterization of rat mesenchymal stromal cells. Cytotherapy 10:243-253.
23. Mahmood A, D Lu and M Chopp. (2004). Marrow stromal cell transplantation after traumatic brain injury promotes cellular proliferation within the brain. Neurosurgery 55:1185-1193.
24. Penkowa M, M Giralt, N Lago, J Camats, J Carrasco, J Hernandez, A Molinero, IL Campbell and J Hidalgo. (2003). Astrocytetargeted expression of IL-6 protects the CNS against a focal brain injury. Exp Neurol 181:130-148.
25. Penkowa M, T Moos, J Carrasco, H Hadberg, A Molinero, H Bluethmann and J Hidalgo. (1999). Strongly compromised infl ammatory response to brain injury in interleukin-6-defi cient mice. Glia 25:343-357.
26. Gao J, JE Dennis, RF Muzic, M Lundberg and AI Caplan. (2001). The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 169:12-20.
27. Fischer UM, MT Harting, F Jimenez, WO Monzon-Posadas, H Xue, SI Savitz, GA Laine and CS Cox. (2009). Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary fi rst pass effect. Stem Cells Dev 18:10.
28. Li Y, J Chen, L Wang, M Lu and M Chopp. (2001). Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 56:1666-1672. (Pubitemid 32574564)
29. Walczak P, J Zhang, AA Gilad, DA Kedziorek, J Ruiz-Cabello, RG Young, MF Pittenger, PC van Zijl, J Huang and JW Bulte. (2008). Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 39:1569-1574.